EUVIMEDEUVIMED entdecken
Crossref

Therapeutic Alliance: Using N-(2,3,4,5,6-Pentahydroxylhex-1-yl)-NDithiocarbamate-L-Isoleucine Disodium to Improve the Toxicity and Survival of Cisplatin Receiving Mice

Yuji Wang, Ming Zhao, Guohui Cui, Chunying Cui, Jingfang Ju, Shiqi Peng

The Open Toxicology Journal · 2008

DOI: 10.2174/1874340400802010001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Open Toxicology Journal, 2008. Verfasst von Yuji Wang und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To reduce the toxicity of cisplatin N-(2,3,4,5,6-pentahydroxylhex-1-yl)-N-dithiocarbamate-L-isoleucine disodium (GID) based therapeutic alliance is investigated.For the proliferation of HepG 2 , Hela, MES-SA, HL 60 and H1299 cells, 27μM of GID based therapeutic alliance gave comparable inhibition to cisplatin alone.For implanted tumor proliferation in mice, 1.667μmol/kg of GID based therapeutic alliance gave higher inhibition than cisplatin alone.For cisplatin receiving mice, this therapeutic alliance effectively reduces the platinum accumulations in the organs but does not affect the platinum level in the tumor tissue.Comparing to cisplatin alone, this therapeutic alliance not only increases urea and fecal platinum levels but also increases urea excretion.All the observations imply that GID based therapeutic alliance is capable of reducing the toxicity and supporting the anti-tumor potency of cisplatin.

Zitieren

APA

Wang, Y., Zhao, M., Cui, G., Cui, C., Ju, J., & Peng, S. (2008). Therapeutic Alliance: Using N-(2,3,4,5,6-Pentahydroxylhex-1-yl)-NDithiocarbamate-L-Isoleucine Disodium to Improve the Toxicity and Survival of Cisplatin Receiving Mice. The Open Toxicology Journal. https://doi.org/10.2174/1874340400802010001

Vancouver

Wang Y, Zhao M, Cui G, Cui C, Ju J, Peng S. Therapeutic Alliance: Using N-(2,3,4,5,6-Pentahydroxylhex-1-yl)-NDithiocarbamate-L-Isoleucine Disodium to Improve the Toxicity and Survival of Cisplatin Receiving Mice. The Open Toxicology Journal. 2008. doi:10.2174/1874340400802010001

BibTeX
@article{Wang2008,
  author = {Wang, Yuji and Zhao, Ming and Cui, Guohui and Cui, Chunying and Ju, Jingfang and Peng, Shiqi},
  title = {Therapeutic Alliance: Using N-(2,3,4,5,6-Pentahydroxylhex-1-yl)-NDithiocarbamate-L-Isoleucine Disodium to Improve the Toxicity and Survival of Cisplatin Receiving Mice},
  journal = {The Open Toxicology Journal},
  year = {2008},
  doi = {10.2174/1874340400802010001}
}
Kostenlos starten →